Danazol/ sorafenib

In: Reactions Weekly · 2015 · vol. 1551(1) , pp. 105 · doi:10.1007/s40278-015-0657-z · W4241677816
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-09-03 ⓘ

The provided text contains only the title "Danazol/ sorafenib" and lacks an abstract or descriptive content, making it impossible to summarize the research findings or its relation to endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-05-10T17:50:55.020844+00:00
License: CC0 · commercial use OK